Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Express Scripts
Baxter
Colorcon
Harvard Business School

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Fluoride ion

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Fluoride ion: Sponsors, patents, clinical trial progress

Fluoride ion is an investigational drug.

There have been 4 clinical trials for Fluoride ion. The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2011.

The most common disease conditions in clinical trials are Dental Caries and [disabled in preview]. The leading clinical trial sponsors are University of Campinas, Brazil, Yonsei University, and University of Iowa.

There are seventy-eight US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Fluoride ion
TitleSponsorPhase
Silver Diamine Fluoride Pilot Study (SDF)University of IowaPhase 0
Long-term Release of Fluoride Formed on Enamel by Fluoride Gel or Varnish to Biofilm FluidUniversity of Campinas, BrazilPhase 0
A Comparison of Kidney Function After Nephrectomy in Living Donors Under Sevoflurane and Desflurane AnesthesiaYonsei UniversityN/A

See all Fluoride ion clinical trials

Clinical Trial Summary for Fluoride ion

Top disease conditions for Fluoride ion
Top clinical trial sponsors for Fluoride ion

See all Fluoride ion clinical trials

US Patents for Fluoride ion

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fluoride ion   See Pricing Processes for coated carrier particles Xerox Corporation (Stamford, CT)   See Pricing
Fluoride ion   See Pricing Process for the preparation of difluoromaleic anhydride E. I. Du Pont de Nemours and Company (Wilmington, DE)   See Pricing
Fluoride ion   See Pricing Herbicidal oxabicycloalkane ethers E.I. Du Pont de Nemours and Company (Wilmington, DE)   See Pricing
Fluoride ion   See Pricing Treatment of congestive heart failure with angiotensin 11 receptor blocking imidazoles E. I. Du Pont de Nemours and Company (Wilmington, DE)   See Pricing
Fluoride ion   See Pricing Angiotensin II receptor blocking imidazoles E. I. Du Pont de Nemours and Company (Wilmington, DE)   See Pricing
Fluoride ion   See Pricing Treatment of hypertension with angiotensin II blocking imidazoles E. I. du Pont de Nemours and Company (Wilmington, DE)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Fluoride ion

Drugname Country Document Number Estimated Expiration Related US Patent
Fluoride ion Japan 3139715 2010-02-26   See Pricing
Fluoride ion Japan H06214430 2010-02-26   See Pricing
Fluoride ion Austria 96799 2008-05-23   See Pricing
Fluoride ion Brazil 8907445 2008-05-23   See Pricing
Fluoride ion China 1038281 2008-05-23   See Pricing
Fluoride ion Germany 68910382 2008-05-23   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Mallinckrodt
Express Scripts
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.